SIX1 and Hodgkins lymphoma: Moreover, treatment of L-428 and U-HO1 with WNT-signalling inhibitor IWR mediated reduction of SIX1 expression (Fig. 4B), supporting an activatory impact of the WNT-signalling pathway on SIX1 in HL.